Ligand validation:5I9X

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5I9X_EDO_A_1002	84%	89%	0.12	0.983	0.45	0.19	-	-	0	0	100%	1
5I9X_EDO_A_1003	76%	74%	0.1	0.936	0.44	0.57	-	-	0	0	100%	1
5I9X_EDO_A_1004	44%	84%	0.13	0.855	0.39	0.38	-	-	0	0	100%	1
5I9X_EDO_A_1005	11%	63%	0.201	0.717	0.36	1.05	-	-	3	0	100%	1
6FNG_EDO_A_1003	94%	82%	0.077	0.976	0.46	0.34	-	-	0	0	100%	1
6FNH_EDO_C_1003	92%	83%	0.052	0.943	0.43	0.35	-	-	0	0	100%	1
5IA4_EDO_A_1002	4%	79%	0.248	0.615	0.48	0.39	-	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4ITB_EDO_A_503	100%	88%	0.028	0.99	0.38	0.29	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.